Trademark Overview
On Wednesday, February 4, 2026, a trademark application was filed for TRANSFORMING VACCINES with the United States Patent and Trademark Office. The USPTO has given the TRANSFORMING VACCINES trademark a serial number of 99633983. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 4, 2026. This trademark is owned by Verndari, Inc.. The TRANSFORMING VACCINES trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Intradermal patches being adhesive drug delivery patches, sold without medication; Microarray patches being adhesive drug delivery devices, sold without medication
Vaccines; Vaccine delivery patches being transdermal patches featuring vaccines; Intradermal patches being adhesive drug delivery patches impregnated with vaccines; Intradermal patches being adhesive drug delivery patches impregnated with pharmaceutical preparations for the treatment of infectious diseases; Microarray patches being adhesive drug delivery devices impregnated with vaccines; Microarray patches being adhesive drug delivery devices impregnated with pharmaceutical preparations for the treatment of infectious diseases; Intradermal patches being adhesive drug delivery patches and microarray patches being adhesive drug delivery devices, all sold filled with therapeutic agents used for the stabilization and delivery of vaccines; Pharmaceutical preparations for the prevention and treatment of infectious diseases; Vaccination kits comprised primarily of therapeutic vaccine preparations and Intradermal patches being adhesive drug delivery patches
Research and development services in the fields of vaccines, vaccine and drug delivery technologies, intradermal drug and vaccine delivery technologies, and microarray drug and vaccine delivery technologies; Providing medical research information in the fields of vaccines, vaccine and drug delivery technologies, intradermal drug and vaccine delivery technologies, and microarray drug and vaccine delivery technologies